Drug Profile
Research programme: membrane protein inhibitors - Pfizer
Alternative Names: Efflux pump inhibitors research programme - PfizerLatest Information Update: 05 Aug 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 05 Aug 2009 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 02 Feb 2006 Preclinical trials in Bacterial infections in USA (unspecified route)